MX340487B - Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. - Google Patents

Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.

Info

Publication number
MX340487B
MX340487B MX2013004457A MX2013004457A MX340487B MX 340487 B MX340487 B MX 340487B MX 2013004457 A MX2013004457 A MX 2013004457A MX 2013004457 A MX2013004457 A MX 2013004457A MX 340487 B MX340487 B MX 340487B
Authority
MX
Mexico
Prior art keywords
diagnosing
diseases
imaging
compounds
treatment
Prior art date
Application number
MX2013004457A
Other languages
English (en)
Other versions
MX2013004457A (es
Inventor
Lehmann Lutz
Andrea Thiele
Kettschau Georg
Heinrich Tobias
Nag Sangram
Varrone Andrea
Gulyas Balazs
Halldin Christer
Original Assignee
Piramal Imaging Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Imaging Sa filed Critical Piramal Imaging Sa
Publication of MX2013004457A publication Critical patent/MX2013004457A/es
Publication of MX340487B publication Critical patent/MX340487B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se relaciona con compuestos novedosos adecuados como precursores para la preparación de ciertos trazadores de tomografía de emisión positrónica (PET) marcados con 18F. Además, la invención se relaciona con la preparación de esas moléculas precursoras y con la preparación de trazadores de PET por marcación con 18F de esos precursores.
MX2013004457A 2010-10-22 2011-10-17 Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. MX340487B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10188559A EP2450332A1 (en) 2010-10-22 2010-10-22 Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl)
PCT/EP2011/068124 WO2012052409A1 (en) 2010-10-22 2011-10-17 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system

Publications (2)

Publication Number Publication Date
MX2013004457A MX2013004457A (es) 2013-09-16
MX340487B true MX340487B (es) 2016-07-11

Family

ID=43760025

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004457A MX340487B (es) 2010-10-22 2011-10-17 Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.

Country Status (18)

Country Link
US (1) US9314540B2 (es)
EP (2) EP2450332A1 (es)
JP (1) JP5964840B2 (es)
KR (1) KR101852647B1 (es)
CN (2) CN104478735B (es)
AR (1) AR083519A1 (es)
AU (1) AU2011317664A1 (es)
BR (1) BR112013009861A2 (es)
CA (1) CA2815401C (es)
DK (1) DK2630104T3 (es)
EA (1) EA023820B1 (es)
HK (1) HK1203190A1 (es)
IL (1) IL225855A0 (es)
MX (1) MX340487B (es)
NZ (1) NZ610736A (es)
SG (1) SG189478A1 (es)
TW (1) TW201225979A (es)
WO (1) WO2012052409A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
WO2015143019A2 (en) * 2014-03-18 2015-09-24 Mayo Foundation For Medical Education And Research Gaseous f-18 technologies
PT3143011T (pt) * 2014-05-13 2021-04-26 Hoffmann La Roche Compostos heterocíclicos deuterados e a sua utilização como agentes de imagiologia
CN107445798B (zh) * 2016-06-01 2020-11-03 中国农业大学 一种α,α‐二氘代醇类化合物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ302723A (en) * 1995-03-02 1998-04-27 Scherer Ltd R P Composition comprising monoamine oxidase b inhibitor and a carrier formulated for pre-gastric absorption of the monoamine oxidase b inhibitor
EP1104174A4 (en) * 1998-06-09 2006-08-02 Matsushita Electric Ind Co Ltd IMAGE CODERS, IMAGE DECODERS, CHARACTERS AND DATA STORAGE MEDIUM
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
JP5647227B2 (ja) 2009-04-23 2014-12-24 ピラマル イメージング ソシエテ アノニム Ｆ−１８ラベルされたｐｅｔトレーサーのための新規前駆体分子

Also Published As

Publication number Publication date
WO2012052409A1 (en) 2012-04-26
US20130336890A1 (en) 2013-12-19
US9314540B2 (en) 2016-04-19
MX2013004457A (es) 2013-09-16
AR083519A1 (es) 2013-03-06
JP2014502257A (ja) 2014-01-30
CN104478735A (zh) 2015-04-01
KR20140023870A (ko) 2014-02-27
DK2630104T3 (en) 2018-07-16
IL225855A0 (en) 2013-07-31
EP2630104B1 (en) 2018-04-04
EA201300479A1 (ru) 2013-10-30
KR101852647B1 (ko) 2018-04-26
AU2011317664A1 (en) 2013-05-23
HK1203190A1 (en) 2015-10-23
SG189478A1 (en) 2013-05-31
EP2630104A1 (en) 2013-08-28
CN104478735B (zh) 2017-05-31
CA2815401C (en) 2019-04-09
EA023820B1 (ru) 2016-07-29
CA2815401A1 (en) 2012-04-26
NZ610736A (en) 2014-11-28
BR112013009861A2 (pt) 2019-09-24
TW201225979A (en) 2012-07-01
EP2450332A1 (en) 2012-05-09
JP5964840B2 (ja) 2016-08-03
CN103443056A (zh) 2013-12-11

Similar Documents

Publication Publication Date Title
NZ590923A (en) Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
MX2021008976A (es) Inhibidores marcados de antigeno prostatico especifico de membrama (psma), su uso como agentes formadores de imagenes y agentes farmaceuticos para el tratamiento de cancer de prostata.
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
WO2009052970A3 (en) Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
BR112012016376A2 (pt) compostos de pirrolo-aminopirimida substituída
EP2576578A4 (en) POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
PH12015500252A1 (en) Niclosamide for the treatment of solid tumors
SG10201810357WA (en) Ly75 as cancer therapeutic and diagnostic target
PL2771329T3 (pl) Nowe związki di-podstawione 3,4-diamino-3-cyklobuteno- 1,2-dionu do zastosowania w leczeniu patologii, w których pośredniczą chemokiny
MX2011010295A (es) Reactivos de radiomarcado y metodos.
WO2012116196A3 (en) Substituted lactosyl compounds and use thereof for cellular imaging and therapy
MX340487B (es) Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
GB201121914D0 (en) Method for patient selection
MX2013006202A (es) Metodo de radioconjugacion.
MX2013012795A (es) Procursores novedosos de derivados de glutamato.
IN2014DN10081A (es)
WO2012151464A3 (en) Use of radiographic contrast agents for detecting dental caries
MX340407B (es) Simplificacion de proceso para compuesto precursor.
MX2013010781A (es) Compuestos para usarse en formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central.
BR112013006498A2 (pt) composto
MX2011011191A (es) Nuevas moléculas precursoras para marcadores de pet marcados con f-18.
GB201205703D0 (en) Synthon composition
NZ708849A (en) Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma

Legal Events

Date Code Title Description
FG Grant or registration